José Cândido Caldeira Xavier‐Júnior

ORCID: 0000-0003-0503-419X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cutaneous Melanoma Detection and Management
  • Cutaneous lymphoproliferative disorders research
  • Salivary Gland Tumors Diagnosis and Treatment
  • Cervical Cancer and HPV Research
  • Nonmelanoma Skin Cancer Studies
  • Thyroid Cancer Diagnosis and Treatment
  • Tumors and Oncological Cases
  • Cancer and Skin Lesions
  • Viral-associated cancers and disorders
  • Oral and Maxillofacial Pathology
  • Genital Health and Disease
  • Sarcoma Diagnosis and Treatment
  • Ear and Head Tumors
  • Lymphoma Diagnosis and Treatment
  • Fungal Infections and Studies
  • Infectious Diseases and Mycology
  • Head and Neck Anomalies
  • Women's cancer prevention and management
  • Genetic and rare skin diseases.
  • Global Cancer Incidence and Screening
  • CAR-T cell therapy research
  • Cancer Diagnosis and Treatment
  • Immunotherapy and Immune Responses
  • Nail Diseases and Treatments
  • Autoimmune Bullous Skin Diseases

Instituto de Oncologia do Paraná
2017-2024

Centro Universitário Católico Salesiano Auxilium
2018-2024

Universidade Estadual Paulista (Unesp)
2013-2024

Pontifícia Universidade Católica de São Paulo
2020-2024

Santa Casa Hospital
2024

University of Cagliari
2023

Universidade Paulista
2022

Centro Universitario Toledo
2018

Universidade de São Paulo
2015-2017

Administração Regional de Saúde de Lisboa e Vale do Tejo
2012

Xavier-Junior, José Cândido Caldeira MD, PhD; Ocanha‐Xavier, Juliana Polizel MSc Author Information

10.1097/dad.0000000000001446 article PT American Journal of Dermatopathology 2019-05-20
Fabio Medas Chiara Dobrinja Ebtesam A. Al-Suhaimi Julia Altmeier Said Anajar and 95 more Akif Enes Arıkan Irina Azaryan Lovenish Bains G Basili Hakan Bölükbaşı Marco Bononi Farzad Borumandi Mehmet Buğra Bozan Gabriela Brenta Laurent Brunaud Maximilian Brunner Antoine Buémi Gian Luigi Canu Federico Cappellacci Sara Cartwright Ignasi Castells Fusté Beatriz Godói Cavalheiro Giuseppe Cavallaro Andrés Chala Shun Yan Bryant Chan John M. Chaplin Mustafa Sajjad Cheema Costanza Chiapponi Maria Grazia Chiofalo Emmanuel Chrysos Annamaria D’Amore Michael de Cillia Carmela De Crea Nicolò de Manzini Leandro Luongo de Matos Loredana De Pasquale Paolo Del Rio Marco Stefano Demarchi Muthuswamy Dhiwakar Gianluca Donatini José Miguel Dora Valerio D’Orazi Viyey Kishore Doulatram Gamgaram Vitalijus Eismontas El Hassane Kabiri Hadj Omar El Malki Islam A. Elzahaby Octavian Enciu Antoine Eskander Francesco Feroci David Figueroa-Bohórquez Dimitrios Filis François Gorostidi Pedro Frías-Fernández Armando Gamboa-Dominguez Volkan Genç Davide Giordano Antonio Gómez-Pedraza Giuseppa Graceffa James D. Griffin Sofia Guerreiro Karan Gupta Keshav Kumar Gupta Angela Gurrado Jiannis Hajiioannou Tommi Hakala Wirsma Arif Harahap Lindsay Hargitai Dana M. Hartl Andrzej Hellmann Jiří Hložek Van Trung Hoang Maurizio Iacobone Nadia Innaro Orestis Ioannidis Joon H. Jang José Cândido Caldeira Xavier‐Júnior Milan Jovanović Reto M. Kaderli Fahmi H. Kakamad Krzysztof Kaliszewski Martin Karamanliev Hiroshi Katoh Andro Košec Božidar Kovačević Luiz Paulo Kowalski Robert Králik Sanjay Kumar Yadav Adriána Kumorová Savvas Lampridis Konstantinos Lasithiotakis J Leclère Eugene Kwong Fei Leong Melvin Khee‐Shing Leow James Lim Leonardo S. Lino‐Silva Shirley Yuk Wah Liu Núria Perucho Llorach Celestino Pio Lombardi Javier López-Gómez

10.1016/s2213-8587(23)00094-3 article EN The Lancet Diabetes & Endocrinology 2023-04-28

Cutaneous melanoma can lead to metastasis, and it is associated with high mortality. Currently, there are no widely accepted immunohistochemistry markers for prognosis in routine staging. Preferentially expressed antigen (PRAME) a possible biomarker several noncutaneous neoplasms. Ki-67 cell proliferation marker correlated poor outcomes many cancers. This study assessed PRAME as potential prognostic sentinel lymph node survival among patients. retrospective analyzing cutaneous cases from...

10.1097/dad.0000000000002863 article EN American Journal of Dermatopathology 2024-10-15

Background Systemic lupus erythematosus (SLE) is a multifactorial autoimmune disease that may affect the oral mucosa. The variable spectrum of lesions observed in SLE can pose challenges diagnosis, particularly when occur isolation. aim this study was to describe occurring patients with from Latin America. Methods This collaborative record-based involving 11 and maxillofacial pathology medicine services across Venezuela, Argentina, Chile, Brazil, Mexico describes clinicopathological profile...

10.1177/09612033241252042 article EN Lupus 2024-04-30

Abstract Melanoma is an aggressive form of skin cancer. Its histopathological diagnosis may be challenging and subject to significant inter- intraobserver variability. It also a disproportionate source pathology malpractice lawsuits worldwide. The knowledge base on melanocytic lesions rapidly expanding, with many recent novel classification systems, therapies molecular targets. Hence, specimens diagnosed or suspected as should carefully appropriately sampled, fixed, processed analyzed...

10.1186/s42047-025-00178-4 article EN cc-by Surgical and Experimental Pathology 2025-03-09

Comprehensive genomic profiling of clinical samples by next-generation sequencing (NGS) can identify one or more therapy targets for the treatment metastatic melanoma (MM) with a single diagnostic test.NGS was performed on hybridization-captured, adaptor ligation-based libraries using DNA extracted from 4 formalin-fixed paraffin-embedded sections cut at 10 microns 30 MM cases. The exons 182 cancer-related genes were fully sequenced Illumina HiSeq 2000 an average depth 1098X and evaluated...

10.1097/dad.0000000000000729 article EN American Journal of Dermatopathology 2016-12-31

Objective To evaluate the association of age at first sexual intercourse with results cervicovaginal cytology. Study Design Observational analytical study about prevalence altered cytology in women aged between 18 and 34 years from a densely populated area Brazil, during 10 years. The patients were stratified into 2 categories according to their (13–16 17–24 years). Results From total 2,505,154 exams, 898,921 tests accordance inclusion criteria. Considering 4 or less as reference, those 5 9...

10.1055/s-0036-1597973 article EN cc-by-nc-nd Revista Brasileira Ginecologia e Obstetrícia 2017-02-01

BACKGROUND: The incidence of melanoma has been increasing in Brazil and all over the world. Despite improvements diagnosis treatment, mortality remains unchanged. OBJECTIVE: To associate clinical histopathological aspects with evolution 136 cases cutaneous melanoma. METHODS: Retrospective cohort study that analyzed patients diagnosed during period from 2003 to 2011, at least 4 years follow up. Archived slides were variables (Breslow, ulceration, mitoses histological regression). Medical...

10.1590/abd1806-4841.20186690 article EN cc-by Anais Brasileiros de Dermatologia 2018-06-01

Abstract In English literature, there are only few reports of Warthin‐like papillary thyroid carcinoma. We presented three cases and provided clinical, grossing, cytological, histological correlation. our point view, the diagnosis carcinoma is feasible based on cytomorphological aspects. Usually those present moderately or highly cellular smears with many atypical Hürthle cells showing obvious nuclear features without structures, even if inflammatory background mild.

10.1002/dc.24292 article EN Diagnostic Cytopathology 2019-09-12

To identify associations between cytological criteria in fine needle aspiration (FNA) specimens and histological subtypes of lobular breast carcinoma (classical other types).FNA cytology mastectomy from 72 cases invasive were consecutively retrieved the files Amaral de Carvalho Hospital, Jaú-São Paulo, Brazil. All reviewed regarding five criteria: cellularity, cellular cohesion, presence inflammation, nucleoli nuclear atypia. The χ2 test or Fisher's exact tests with 95% confidence intervals...

10.1159/000370211 article EN Acta Cytologica 2015-01-01
Coming Soon ...